Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-058593
Filing Date
2023-05-11
Accepted
2023-05-10 18:33:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm232017d2_defa14a.htm DEFA14A 12095
2 GRAPHIC tm232017d2_defa14aimg01.jpg GRAPHIC 123674
3 GRAPHIC tm232017d2_defa14aimg02.jpg GRAPHIC 166071
  Complete submission text file 0001104659-23-058593.txt   412369
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38365 | Film No.: 23908162
SIC: 2834 Pharmaceutical Preparations